Comparative effectiveness of second‐line treatments for epileptic spasms

This updated analysis with an expanded sample size provided power for additional subgroup analysis. Overall response rates were low, and at best only one third had remission after second treatment. Results support a clinical strategy of switching mechanism of action when selecting a second medication for epileptic spasms (i.e., use vigabatrin after hormonal therapy, or hormonal therapy after vigabatrin). Our findings also support the use of standard over nonstandard therapies.

Authors

Institutions

Publication Details

Journal
Epilepsia
Published
2025-06-18
DOI
https://doi.org/10.1111/epi.18511
Citations
3
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
4.41

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative effectiveness of second‐line treatments for epileptic spasms

Zachary M. Grinspan, Renée A. Shellhaas, John R. Mytinger, Ignacio Valencia et al.
3 citations
Epilepsia
Epilepsy research and treatment
4.41
article

Comparative effectiveness of second‐line treatments for epileptic spasms

Zachary M. Grinspan, Renée A. Shellhaas, John R. Mytinger, Ignacio Valencia, Jason Coryell, Shaun A. Hussain, Elissa Yozawitz, Kelly G. Knupp, Wendy G. Mitchell, William D. Gaillard, Anne T. Berg, Courtney J. Wusthoff, Tobias Loddenkemper, Cynthia Keator, Anup D. Patel, Catherine J. Chu, Iván Sánchez Fernández, Nilika S. Singhal, Elaine C. Wirrell, Kristen Barbour, Douglas R. Nordli, Chellamani Harini
article en
3 citations

Abstract

This updated analysis with an expanded sample size provided power for additional subgroup analysis. Overall response rates were low, and at best only one third had remission after second treatment. Results support a clinical strategy of switching mechanism of action when selecting a second medication for epileptic spasms (i.e., use vigabatrin after hormonal therapy, or hormonal therapy after vigabatrin). Our findings also support the use of standard over nonstandard therapies.

EpilepsiaVol. 66(10)
Boston Children's Hospital (US), Albert Einstein College of Medicine (US), Nationwide Children's Hospital (US), Mayo Clinic (US), Children's National (US), Children's Hospital of Los Angeles (US), University of California, Los Angeles (US), Oregon Health & Science University (US), University of California, San Francisco (US), Washington University in St. Louis (US), Cornell University (US), Epilepsy Foundation (US), WinnMed (US), University of California San Diego (US), University of Chicago (US), Massachusetts General Hospital (US), Cook Children's Medical Center (US), Children's Hospital Colorado (US), Children's Hospital at Montefiore (US), Boston Children's Museum (US), Weill Cornell Medicine (US), Drexel University (US), University of California, Davis (US), University of Colorado Denver (US)
American Epilepsy Society, Pediatric Epilepsy Research Foundation, Epilepsiatutkimussäätiö, Epilepsy Society
Good health and well-being
Openalex Percentile: Top 6%
Epilepsy research and treatment
4.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.